Background: Transarterial chemoembolization (TACE), a well-established treatment for unresectable hepatocellular carcinoma (HCC), blocks the arterial blood supply to the tumor, which can be short-lived as development of collateral neovessels, leading to the failure of treatment. Metastasis-associated protein 1 (MTA1) is involved in development of tumors and metastases. However, the role of MTA1 in angiogenesis is still obscure.
Methods: We detected the expression of MTA1 and hypoxia-inducible factor-1 (HIF-1) and microvessel density (MVD) value in liver tumor tissues and tumor periphery before and after TACE treatment. Hepatocellular carcinoma cell line HepG2, tube formation assay, and chorioallantoic membrane (CAM) assay were applied to explore the mechanism of MTA1 in angiogenesis.
Results: We found that expression of MTA1 increased after TACE treatment, especially in tumor periphery, which was accompanied by markedly elevated MVD value, indicating a significant correlation between MTA1 and MVD value. Moreover, MTA1 contributed to neovascularization of residual tumors. Cellular experiments further revealed that MTA1 increased the stability and the expression of HIF-1, and overexpression of MTA1 enhanced tube formation and neovessels of chick embryos.
Conclusions: MTA1 is an active angiogenic regulator; our results shed light on better understanding in neovascularization, which are helpful to predict prognosis of TACE, and provide evidences for intervention to improve therapeutic effects on HCC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447282 | PMC |
| http://dx.doi.org/10.1155/2017/6757898 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inactivation of TACC2 epigenetically represses CDKN1A and confers sensitivity to CDK inhibitors.
Med
January 2025
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China. Electronic address:
Background: The genomic landscape of esophageal squamous cell carcinoma (ESCC) has been characterized extensively, but there remains a significant need for actionable targets and effective therapies.
Methods: Here, we perform integrative analysis of genome-wide loss of heterozygosity and expression to identify potential tumor suppressor genes. The functions and mechanisms of one of the candidates, TACC2, are then explored both in vitro and in vivo, leading to the proposal of a therapeutic strategy based on the concept of synthetic lethality.
Targeting FAK, VEGF, and MTA1 proteins with : a computational approach for anticancer activity.
Front Oncol
September 2024
Department of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
Article Synopsis
- Cancer is a big health problem worldwide, and scientists are looking for new treatments using natural stuff from traditional medicine.
- Recent studies found that certain proteins help cancer cells grow and stay alive, and researchers are testing a natural molecule to see if it can affect these proteins and stop cancer from spreading.
- One natural plant called Terminalia elliptica, has special compounds that might be able to target these proteins, and early tests show they could help in designing new cancer treatments.
Recruitment of the mA/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48.
Genome Biol
September 2024
Donnelly Centre, University of Toronto, Toronto, M5S 3E1, Canada.
Article Synopsis
- N6-methyladenosine (m6A) and N6, 2'-O-dimethyladenosine (m6Am) are crucial modifications on mRNA that influence gene regulation, and the fat mass and obesity-associated protein (FTO) is responsible for removing these modifications.
- The study identifies ZBTB48, a protein involved in telomere maintenance, as a key regulator that interacts with FTO and affects its targeting to m6A/m6Am sites, influencing RNA decay rates.
- The findings suggest that ZBTB48 plays a critical role in modulating FTO’s function and thus the expression of specific transcripts, impacting processes like cancer cell growth.
β-Hydroxybutyrate alleviates brain aging through the MTA1 pathway in D-galactose injured mice.
Eur J Pharmacol
November 2024
The First People's Hospital of Foshan, Foshan, Guangdong province, China. Electronic address:
Aging is an inevitable law of the process of life during which many physiological functions change. Brain aging is an important mechanism in the occurrence and development of degenerative diseases of the central nervous system. β-Hydroxybutyrate (BHBA) is a water-soluble, endogenous small-molecule ketone that can cross the blood-brain barrier and induce neuroprotective effects.
View Article and Find Full Text PDFTranscription factor ZEB1 coordinating with NuRD complex to promote oncogenesis through glycolysis in colorectal cancer.
Front Pharmacol
August 2024
Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Background: Colorectal cancer (CRC) is an aggressive primary intestinal malignancy with the third-highest incidence and second-highest mortality among all cancer types worldwide. Transcription factors (TFs) regulate cell development and differentiation owing to their ability to recognize specific DNA sequences upstream of genes. Numerous studies have demonstrated a strong correlation between TFs, the etiology of tumors, and therapeutic approaches.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!